The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives.
Department of Medical and Surgical Sciences, Center for Applied Biomedical Research (C.R.B.A.), Alma Mater Studiorum University of Bologna, Bologna, Italy.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
CB1 receptor, CB2 receptor, ascites, cirrhotic cardiomyopathy, endocannabinoids, hyperdynamic circulatory syndrome, liver cirrhosis
- [PubMed – as supplied by publisher]